EUVIMEDEUVIMED entdecken
Studienprotokoll

RANDOMISED OPEN CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF BILVA PHAL MAJJA CHURNA IN SUTIKA PANDU W.S.R. TO IRON DEFICIENCY ANEMIA-A STUDY PROTOCOL

Jyoti Bandewar, Priti Pimpalshende, Nikita Dasarwar, Seema Manoorkar, Payal Kamdi, Shubhangi Jadhav, Shrikant Hadole

International Journal of Drug Delivery Technology · 18.06.2026 · 16 (55s)

DOI: 10.25258/ijddt.16.55s.136 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.06.2026. Verfasst von Jyoti Bandewar und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ayurved described the mostly occurring Prasavvyapad in Sutika kal (Postpartum period) is Sutika pandu (Iron Deficiency Anemia). Due to increasing demand of newbie and need of body of mother the circulating red cell mass increases by 20-30%, rise in both cell number and size. It rises more in women with multiple pregnancies. The increase in plasma volume causes haemodilution. In postpartum phase, woman has already low immunity. Diminution and vitiation of Rasa dhatu continued from ante partum phase leading to sutika pandu. Ayurvedic regime of health care and medicinal treatment for this condition is significant called the sutika paricharya, is thoroughly explained in Ayurved Samhita. This study will illustrate the burden of PPA in women and highlights the recent state of the art of PPA management by Ayurvedic holistic approach. Methodology By pilot study drug dose and sample size obtained. IEC approval is taken. CTRI registration done for the trial. Then random sampling will decide the study and control group participants. Both group will receive their decided interventions. Group A will have study drug Bilva fal majja churn 3gm twice after meals with water and Group B control group will have drug Tab. FS once after meals with water for 21 days. Blood sample will be collected before study and after 21 days of treatment for testing the previous and after study value of Hemoglobin and Serum Ferritin. Statistical analysis will be done after completion of treatment to compare the changes in assessment parameters from the baseline. Expected Outcome Study intervention and results will be observed and recorded in terms of value changes in objective and relief of symptoms as per subjective Criteria decided. Results and conclusion will be drawn according to data obtained by statistical analysis.

Zitieren

APA

Bandewar, J., Pimpalshende, P., Dasarwar, N., Manoorkar, S., Kamdi, P., Jadhav, S., & Hadole, S. (2026). RANDOMISED OPEN CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF BILVA PHAL MAJJA CHURNA IN SUTIKA PANDU W.S.R. TO IRON DEFICIENCY ANEMIA-A STUDY PROTOCOL. International Journal of Drug Delivery Technology, 16(55s). https://doi.org/10.25258/ijddt.16.55s.136

Vancouver

Bandewar J, Pimpalshende P, Dasarwar N, Manoorkar S, Kamdi P, Jadhav S, et al. RANDOMISED OPEN CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF BILVA PHAL MAJJA CHURNA IN SUTIKA PANDU W.S.R. TO IRON DEFICIENCY ANEMIA-A STUDY PROTOCOL. International Journal of Drug Delivery Technology. 2026;16(55s). doi:10.25258/ijddt.16.55s.136

BibTeX
@article{Bandewar2026,
  author = {Bandewar, Jyoti and Pimpalshende, Priti and Dasarwar, Nikita and Manoorkar, Seema and Kamdi, Payal and Jadhav, Shubhangi and Hadole, Shrikant},
  title = {RANDOMISED OPEN CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF BILVA PHAL MAJJA CHURNA IN SUTIKA PANDU W.S.R. TO IRON DEFICIENCY ANEMIA-A STUDY PROTOCOL},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {55s},
  doi = {10.25258/ijddt.16.55s.136}
}
Kostenlos starten →